Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

NCT04339764 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

NIH

Sponsor class

Conditions

Dry Age-Related Macular Degeneration
Geographic Atrophy

Interventions

DRUG: iPSC-derived RPE/PLGA transplantation

Sponsor

National Eye Institute (NEI)